FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285013280> ?p ?o ?g. }

• W4285013280 endingPage "107" @default.
• W4285013280 startingPage "97" @default.
• W4285013280 abstract "Background and aims Buprenorphine is an effective medication for opioid use disorder that reduces mortality; however, many patients are not retained in buprenorphine treatment, and an optimal length of treatment after which patients can safely discontinue treatment has not been identified. This study measured the association between buprenorphine treatment duration and all-cause mortality among patients who discontinued treatment. Secondary objectives were to measure the association between treatment duration and drug overdose and opioid-related overdoses. Design Multi-site cohort study. Setting Eight US health systems. Participants Patients who initiated and discontinued buprenorphine treatment between 1 January 2012 and 31 December 2018 (n = 6550). Outcomes occurring after patients discontinued buprenorphine treatment were compared between patients who initiated and discontinued treatment after 8–30, 31–90, 91–180, 181–365 and > 365 days. Measurements Covariate data were obtained from electronic health records (EHRs). Mortality outcomes were derived from EHRs and state vital statistics. Non-fatal opioid and drug overdoses were obtained from diagnostic codes. Four sites provided cause-of-death data to identify fatal drug and opioid-related overdoses. Adjusted frailty regression was conducted on a propensity-weighted cohort to assess associations between duration of the final treatment episode and outcomes. Findings The mortality rate after buprenorphine treatment was 1.82 per 100 person-years (n = 191 deaths). In regression analyses with > 365 days as the reference group, treatment duration was not associated with all-cause mortality and drug overdose (P > 0.05 for both). However, compared with > 365 days of treatment, 91–180 days of treatment was associated with increased opioid overdose risk (hazard ratio = 2.94, 95% confidence interval = 1.11–7.79). Conclusions Among patients who discontinue buprenorphine treatment, there appears to be no treatment duration period associated with a reduced risk for all-cause mortality. Patients who discontinue buprenorphine treatment after 91–180 days appear to be at heightened risk for opioid overdose compared with patients who discontinue after > 365 days of treatment." @default.
• W4285013280 created "2022-07-12" @default.
• W4285013280 creator A5002030503 @default.
• W4285013280 creator A5006415074 @default.
• W4285013280 creator A5008594003 @default.
• W4285013280 creator A5020580683 @default.
• W4285013280 creator A5021898037 @default.
• W4285013280 creator A5029549144 @default.
• W4285013280 creator A5030006604 @default.
• W4285013280 creator A5030489915 @default.
• W4285013280 creator A5032595749 @default.
• W4285013280 creator A5045869582 @default.
• W4285013280 creator A5051189755 @default.
• W4285013280 creator A5079760655 @default.
• W4285013280 creator A5081829680 @default.
• W4285013280 creator A5082815773 @default.
• W4285013280 creator A5085994871 @default.
• W4285013280 date "2022-07-23" @default.
• W4285013280 modified "2023-10-14" @default.
• W4285013280 title "The association between buprenorphine treatment duration and mortality: a multi‐site cohort study of people who discontinued treatment" @default.
• W4285013280 cites W1607437209 @default.
• W4285013280 cites W1687925784 @default.
• W4285013280 cites W1965862609 @default.
• W4285013280 cites W1970939183 @default.
• W4285013280 cites W2003884991 @default.
• W4285013280 cites W2034948055 @default.
• W4285013280 cites W2056108924 @default.
• W4285013280 cites W2061326496 @default.
• W4285013280 cites W2111714917 @default.
• W4285013280 cites W2125182403 @default.
• W4285013280 cites W2126049444 @default.
• W4285013280 cites W2132974770 @default.
• W4285013280 cites W2207604103 @default.
• W4285013280 cites W2248705888 @default.
• W4285013280 cites W2564687864 @default.
• W4285013280 cites W2579244951 @default.
• W4285013280 cites W2608446001 @default.
• W4285013280 cites W2609185034 @default.
• W4285013280 cites W2610572186 @default.
• W4285013280 cites W2781874148 @default.
• W4285013280 cites W2790223969 @default.
• W4285013280 cites W2799522112 @default.
• W4285013280 cites W2801711697 @default.
• W4285013280 cites W2808907017 @default.
• W4285013280 cites W2887297165 @default.
• W4285013280 cites W2890254074 @default.
• W4285013280 cites W2945149268 @default.
• W4285013280 cites W2962856113 @default.
• W4285013280 cites W2990187794 @default.
• W4285013280 cites W2991409330 @default.
• W4285013280 cites W3013744961 @default.
• W4285013280 cites W3165633131 @default.
• W4285013280 cites W3205115907 @default.
• W4285013280 cites W4285013280 @default.
• W4285013280 cites W584648207 @default.
• W4285013280 doi "https://doi.org/10.1111/add.15998" @default.
• W4285013280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35815386" @default.
• W4285013280 hasPublicationYear "2022" @default.
• W4285013280 type Work @default.
• W4285013280 citedByCount "5" @default.
• W4285013280 countsByYear W42850132802022 @default.
• W4285013280 countsByYear W42850132802023 @default.
• W4285013280 crossrefType "journal-article" @default.
• W4285013280 hasAuthorship W4285013280A5002030503 @default.
• W4285013280 hasAuthorship W4285013280A5006415074 @default.
• W4285013280 hasAuthorship W4285013280A5008594003 @default.
• W4285013280 hasAuthorship W4285013280A5020580683 @default.
• W4285013280 hasAuthorship W4285013280A5021898037 @default.
• W4285013280 hasAuthorship W4285013280A5029549144 @default.
• W4285013280 hasAuthorship W4285013280A5030006604 @default.
• W4285013280 hasAuthorship W4285013280A5030489915 @default.
• W4285013280 hasAuthorship W4285013280A5032595749 @default.
• W4285013280 hasAuthorship W4285013280A5045869582 @default.
• W4285013280 hasAuthorship W4285013280A5051189755 @default.
• W4285013280 hasAuthorship W4285013280A5079760655 @default.
• W4285013280 hasAuthorship W4285013280A5081829680 @default.
• W4285013280 hasAuthorship W4285013280A5082815773 @default.
• W4285013280 hasAuthorship W4285013280A5085994871 @default.
• W4285013280 hasBestOaLocation W42850132801 @default.
• W4285013280 hasConcept C126322002 @default.
• W4285013280 hasConcept C167135981 @default.
• W4285013280 hasConcept C170493617 @default.
• W4285013280 hasConcept C194828623 @default.
• W4285013280 hasConcept C201903717 @default.
• W4285013280 hasConcept C2776315796 @default.
• W4285013280 hasConcept C2778949969 @default.
• W4285013280 hasConcept C2779418921 @default.
• W4285013280 hasConcept C2781063702 @default.
• W4285013280 hasConcept C3017944768 @default.
• W4285013280 hasConcept C71924100 @default.
• W4285013280 hasConcept C72563966 @default.
• W4285013280 hasConceptScore W4285013280C126322002 @default.
• W4285013280 hasConceptScore W4285013280C167135981 @default.
• W4285013280 hasConceptScore W4285013280C170493617 @default.
• W4285013280 hasConceptScore W4285013280C194828623 @default.
• W4285013280 hasConceptScore W4285013280C201903717 @default.
• W4285013280 hasConceptScore W4285013280C2776315796 @default.
• W4285013280 hasConceptScore W4285013280C2778949969 @default.

• next